Catalyst Pharmaceuticals Inc (CPRX)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	163,889	142,797	68,149	65,117	71,410	62,037	115,549	99,406	83,079	66,917	54,498	45,060	39,482	41,610	74,621	72,220	74,983	71,476	41,766	42,946
Revenue (ttm)	US$ in thousands	491,734	460,482	434,475	411,347	398,204	348,393	302,949	256,480	214,203	191,755	170,465	153,717	140,833	133,539	126,902	120,142	119,073	118,181	119,761	118,994
Net profit margin		33.33%	31.01%	15.69%	15.83%	17.93%	17.81%	38.14%	38.76%	38.79%	34.90%	31.97%	29.31%	28.03%	31.16%	58.80%	60.11%	62.97%	60.48%	34.87%	36.09%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $163,889K ÷ $491,734K
= 33.33%

Over the analyzed periods, Catalyst Pharmaceuticals Inc's net profit margin has shown fluctuations. The company's net profit margin reached its highest point in December 2024 at 33.33%, indicating that the company's profits were 33.33% of its total revenue during that period. However, it is important to note that there was a significant decrease in the net profit margin from March 2024 to June 2024, dropping from 15.83% to 15.69%.

The highest net profit margin performance was noted in December 2020, with a margin of 62.97%, and this was followed by another strong performance in March 2023 at 38.76%. On the contrary, the lowest net profit margin was recorded in December 2023 at 17.93%.

Overall, Catalyst Pharmaceuticals Inc's net profit margin has varied significantly over the periods, showing both peaks and troughs. It is essential for the company to focus on sustaining profitability by effectively managing costs and enhancing revenue generation in order to stabilize and improve its net profit margin in the long term.